Anti-DRAXIN/C1orf187 antibody

Cat.#: 105232

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-DRAXIN/C1orf187 antibody
  • Documents
  • Description
    Rabbit polyclonal to DRAXIN/C1orf187
  • Tested applications
    ELISA, WB
  • Species reactivity
    Human DRAXIN
  • Alternative names
    neucrin antibody; C1orf187 antibody; UNQ3119 antibody; AGPA3119 antibody; neucrin antibody; 2610109H07Rik antibody; neucrin antibody; 2610109H07Rik antibody; UNQ3119 antibody; neucrin antibody; AGPA3119 antibody; C1orf187 antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Human DRAXIN (rh DRAXIN; NP_940947.3; Met1-Val349). DRAXIN specific IgG was purified by Human DRAXIN affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    WB: 10-20 μg/ml

    ELISA: 0.1-0.2 μg/mL

    This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human DRAXIN. The detection limit for Human DRAXIN is < 0.039 ng/well.

  • Validations

    DRAXIN Antibody, Rabbit PAb, Antigen Affinity Purified, Western blot

    DRAXIN Antibody, Rabbit PAb, Antigen Affinity Purified, Western blot

  • Background
    Chemorepulsive axon guidance protein required for the development of spinal cord and forebrain commissures. Acts as a chemorepulsive guidance protein for commissural axons during development. Able to inhibit or repel neurite outgrowth from dorsal spinal cord. Inhibits the stabilization of cytosolic beta-catenin (CTNNB1) via its interaction with LRP6, thereby acting as an antagonist of Wnt signaling pathway.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"